Europe Lung Cancer Vaccines Sales Market Report 2021

August 2016 | 108 pages | ID: E1B6299E8A2EN
QYResearch

Abstracts

This report studies sales (consumption) of Lung Cancer Vaccines in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Boehringer Ingelheim
• CureVac
• Eli Lily
• GlaxoSmithKline
• ImClone Systems
• Merck
• Ono Pharmaceutical
• Oncothyreon Incorporation

Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Lung Cancer Vaccines in these regions, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Italy
• Spain
• Russia

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type 1
• Type 2
• Type 3

Split by applications, this report focuses on sales, market share and growth rate of Lung Cancer Vaccines in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

1 LUNG CANCER VACCINES OVERVIEW

1.1 Product Overview and Scope of Lung Cancer Vaccines
1.2 Classification of Lung Cancer Vaccines
1.3 Applications of Lung Cancer Vaccines
1.4 Lung Cancer Vaccines Market by Regions
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Italy Status and Prospect (2011-2021)
  1.4.5 Spain Status and Prospect (2011-2021)
  1.4.6 Russia Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Lung Cancer Vaccines (2011-2021)
  1.5.1 Europe Lung Cancer Vaccines Sales, Revenue and Price (2011-2021)
  1.5.2 Europe Lung Cancer Vaccines Sales and Growth Rate (2011-2021)
  1.5.3 Europe Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)

2 EUROPE LUNG CANCER VACCINES BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Lung Cancer Vaccines Market Competition by Manufacturers
  2.1.1 Europe Lung Cancer Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Lung Cancer Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Lung Cancer Vaccines (Volume and Value) by Type
  2.2.1 Europe Lung Cancer Vaccines Sales and Market Share by Type (2011-2021)
  2.2.2 Europe Lung Cancer Vaccines Revenue and Market Share by Type (2011-2021)
2.3 Europe Lung Cancer Vaccines (Volume and Value) by Regions
  2.3.1 Europe Lung Cancer Vaccines Sales and Market Share by Regions (2011-2021)
  2.3.2 Europe Lung Cancer Vaccines Revenue and Market Share by Regions (2011-2021)
2.4 Europe Lung Cancer Vaccines (Volume) by Application

3 GERMANY LUNG CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Lung Cancer Vaccines Sales and Value (2011-2021)
  3.1.1 Germany Lung Cancer Vaccines Sales and Growth Rate (2011-2021)
  3.1.2 Germany Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
  3.1.3 Germany Lung Cancer Vaccines Sales Price Trend (2011-2021)
3.2 Germany Lung Cancer Vaccines Sales and Market Share by Manufacturers
3.3 Germany Lung Cancer Vaccines Sales and Market Share by Type
3.4 Germany Lung Cancer Vaccines Sales and Market Share by Applications

4 UK LUNG CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

4.1 UK Lung Cancer Vaccines Sales and Value (2011-2021)
  4.1.1 UK Lung Cancer Vaccines Sales and Growth Rate (2011-2021)
  4.1.2 UK Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
  4.1.3 UK Lung Cancer Vaccines Sales Price Trend (2011-2021)
4.2 UK Lung Cancer Vaccines Sales and Market Share by Manufacturers
4.3 UK Lung Cancer Vaccines Sales and Market Share by Type
4.4 UK Lung Cancer Vaccines Sales and Market Share by Applications

5 FRANCE LUNG CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

5.1 France Lung Cancer Vaccines Sales and Value (2011-2021)
  5.1.1 France Lung Cancer Vaccines Sales and Growth Rate (2011-2021)
  5.1.2 France Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
  5.1.3 France Lung Cancer Vaccines Sales Price Trend (2011-2021)
5.2 France Lung Cancer Vaccines Sales and Market Share by Manufacturers
5.3 France Lung Cancer Vaccines Sales and Market Share by Type
5.4 France Lung Cancer Vaccines Sales and Market Share by Applications

6 ITALY LUNG CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Italy Lung Cancer Vaccines Sales and Value (2011-2021)
  6.1.1 Italy Lung Cancer Vaccines Sales and Growth Rate (2011-2021)
  6.1.2 Italy Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
  6.1.3 Italy Lung Cancer Vaccines Sales Price Trend (2011-2021)
6.2 Italy Lung Cancer Vaccines Sales and Market Share by Manufacturers
6.3 Italy Lung Cancer Vaccines Sales and Market Share by Type
6.4 Italy Lung Cancer Vaccines Sales and Market Share by Applications

7 RUSSIA LUNG CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 Russia Lung Cancer Vaccines Sales and Value (2011-2021)
  7.1.1 Russia Lung Cancer Vaccines Sales and Growth Rate (2011-2021)
  7.1.2 Russia Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
  7.1.3 Russia Lung Cancer Vaccines Sales Price Trend (2011-2021)
7.2 Russia Lung Cancer Vaccines Sales and Market Share by Manufacturers
7.3 Russia Lung Cancer Vaccines Sales and Market Share by Type
7.4 Russia Lung Cancer Vaccines Sales and Market Share by Applications

8 SPAIN LUNG CANCER VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Lung Cancer Vaccines Sales and Value (2011-2021)
  8.1.1 Spain Lung Cancer Vaccines Sales and Growth Rate (2011-2021)
  8.1.2 Spain Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
  8.1.3 Spain Lung Cancer Vaccines Sales Price Trend (2011-2021)
8.2 Spain Lung Cancer Vaccines Sales and Market Share by Manufacturers
8.3 Spain Lung Cancer Vaccines Sales and Market Share by Type
8.4 Spain Lung Cancer Vaccines Sales and Market Share by Applications

9 EUROPE LUNG CANCER VACCINES MANUFACTURERS ANALYSIS

9.1 Boehringer Ingelheim
  9.1.1 Company Basic Information,Manufacturing Base and Competitors
  9.1.2 Lung Cancer Vaccines Product Type and Technology
    9.1.2.1 Type
    9.1.2.2 Type
  9.1.3 Lung Cancer Vaccines Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)
9.2 CureVac
  9.2.1 Company Basic Information,Manufacturing Base and Competitors
  9.2.2 Lung Cancer Vaccines Product Type and Technology
    9.2.2.1 Type
    9.2.2.2 Type
  9.2.3 Lung Cancer Vaccines Sales, Revenue, Price of CureVac (2015 and 2016)
9.3 Eli Lily
  9.3.1 Company Basic Information,Manufacturing Base and Competitors
  9.3.2 Lung Cancer Vaccines Product Type and Technology
    9.3.2.1 Type
    9.3.2.2 Type
  9.3.3 Lung Cancer Vaccines Sales, Revenue, Price of Eli Lily (2015 and 2016)
9.4 GlaxoSmithKline
  9.4.1 Company Basic Information,Manufacturing Base and Competitors
  9.4.2 Lung Cancer Vaccines Product Type and Technology
    9.4.2.1 Type
    9.4.2.2 Type
  9.4.3 Lung Cancer Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
9.5 ImClone Systems
  9.5.1 Company Basic Information,Manufacturing Base and Competitors
  9.5.2 Lung Cancer Vaccines Product Type and Technology
    9.5.2.1 Type
    9.5.2.2 Type
  9.5.3 Lung Cancer Vaccines Sales, Revenue, Price of ImClone Systems (2015 and 2016)
9.6 Merck
  9.6.1 Company Basic Information,Manufacturing Base and Competitors
  9.6.2 Lung Cancer Vaccines Product Type and Technology
    9.6.2.1 Type
    9.6.2.2 Type
  9.6.3 Lung Cancer Vaccines Sales, Revenue, Price of Merck (2015 and 2016)
9.7 Ono Pharmaceutical
  9.7.1 Company Basic Information,Manufacturing Base and Competitors
  9.7.2 Lung Cancer Vaccines Product Type and Technology
    9.7.2.1 Type
    9.7.2.2 Type
  9.7.3 Lung Cancer Vaccines Sales, Revenue, Price of Ono Pharmaceutical (2015 and 2016)
9.8 Oncothyreon Incorporation
  9.8.1 Company Basic Information,Manufacturing Base and Competitors
  9.8.2 Lung Cancer Vaccines Product Type and Technology
    9.8.2.1 Type
    9.8.2.2 Type
  9.8.3 Lung Cancer Vaccines Sales, Revenue, Price of Oncothyreon Incorporation (2015 and 2016)

10 LUNG CANCER VACCINES TECHNOLOGY AND DEVELOPMENT TREND

10.1 Lung Cancer Vaccines Technology Analysis
10.2 Lung Cancer Vaccines Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Lung Cancer Vaccines
Table Classification of Lung Cancer Vaccines
Figure Europe Sales Market Share of Lung Cancer Vaccines by Types in 2015
Table Applications of Lung Cancer Vaccines
Figure Europe Sales Market Share of Lung Cancer Vaccines by Applications in 2015
Figure Germany Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure France Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure UK Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Italy Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Spain Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Russia Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
Table Europe Lung Cancer Vaccines Sales, Revenue and Price (2011-2021)
Figure Europe Lung Cancer Vaccines Sales and Growth Rate (2011-2021)
Figure Europe Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
Table Europe Lung Cancer Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Europe Lung Cancer Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Lung Cancer Vaccines Sales Share by Manufacturers
Figure 2016 Lung Cancer Vaccines Sales Share by Manufacturers
Table Europe Lung Cancer Vaccines Revenue by Manufacturers (2015 and 2016)
Table Europe Lung Cancer Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Lung Cancer Vaccines Revenue Share by Manufacturers
Table 2016 Europe Lung Cancer Vaccines Revenue Share by Manufacturers
Table Europe Lung Cancer Vaccines Sales and Market Share by Type (2011-2021)
Table Europe Lung Cancer Vaccines Sales Share by Type (2011-2021)
Figure Sales Market Share of Lung Cancer Vaccines by Type (2011-2021)
Figure Europe Lung Cancer Vaccines Sales Growth Rate by Type (2011-2021)
Table Europe Lung Cancer Vaccines Revenue and Market Share by Type (2011-2021)
Table Europe Lung Cancer Vaccines Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Lung Cancer Vaccines by Type (2011-2021)
Figure Europe Lung Cancer Vaccines Revenue Growth Rate by Type (2011-2021)
Table Europe Lung Cancer Vaccines Sales and Market Share by Regions (2011-2021)
Table Europe Lung Cancer Vaccines Sales Share by Regions (2011-2021)
Figure Sales Market Share of Lung Cancer Vaccines by Regions (2011-2021)
Figure Europe Lung Cancer Vaccines Sales Growth Rate by Regions (2011-2021)
Table Europe Lung Cancer Vaccines Revenue and Market Share by Regions (2011-2021)
Table Europe Lung Cancer Vaccines Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Lung Cancer Vaccines by Regions (2011-2021)
Figure Europe Lung Cancer Vaccines Revenue Growth Rate by Regions (2011-2021)
Table Europe Lung Cancer Vaccines Sales and Market Share by Application (2011-2021)
Table Europe Lung Cancer Vaccines Sales Share by Application (2011-2021)
Figure Sales Market Share of Lung Cancer Vaccines by Application (2011-2021)
Figure Europe Lung Cancer Vaccines Sales Growth Rate by Application (2011-2021)
Figure Germany Lung Cancer Vaccines Sales and Growth Rate (2011-2021)
Figure Germany Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Germany Lung Cancer Vaccines Sales Price Trend (2011-2021)
Table Germany Lung Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Germany Lung Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Germany Lung Cancer Vaccines Sales by Type (2015 and 2016)
Table Germany Lung Cancer Vaccines Market Share by Type (2015 and 2016)
Table Germany Lung Cancer Vaccines Sales by Applications (2015 and 2016)
Table Germany Lung Cancer Vaccines Market Share by Applications (2015 and 2016)
Figure UK Lung Cancer Vaccines Sales and Growth Rate (2011-2021)
Figure UK Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure UK Lung Cancer Vaccines Sales Price Trend (2011-2021)
Table UK Lung Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table UK Lung Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table UK Lung Cancer Vaccines Sales by Type (2015 and 2016)
Table UK Lung Cancer Vaccines Market Share by Type (2015 and 2016)
Table UK Lung Cancer Vaccines Sales by Applications (2015 and 2016)
Table UK Lung Cancer Vaccines Market Share by Applications (2015 and 2016)
Figure France Lung Cancer Vaccines Sales and Growth Rate (2011-2021)
Figure France Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure France Lung Cancer Vaccines Sales Price Trend (2011-2021)
Table France Lung Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table France Lung Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table France Lung Cancer Vaccines Sales by Type (2015 and 2016)
Table France Lung Cancer Vaccines Market Share by Type (2015 and 2016)
Table France Lung Cancer Vaccines Sales by Applications (2015 and 2016)
Table France Lung Cancer Vaccines Market Share by Applications (2015 and 2016)
Figure Italy Lung Cancer Vaccines Sales and Growth Rate (2011-2021)
Figure Italy Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Italy Lung Cancer Vaccines Sales Price Trend (2011-2021)
Table Italy Lung Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Italy Lung Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Italy Lung Cancer Vaccines Sales by Type (2015 and 2016)
Table Italy Lung Cancer Vaccines Market Share by Type (2015 and 2016)
Table Italy Lung Cancer Vaccines Sales by Applications (2015 and 2016)
Table Italy Lung Cancer Vaccines Market Share by Applications (2015 and 2016)
Figure Russia Lung Cancer Vaccines Sales and Growth Rate (2011-2021)
Figure Russia Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Russia Lung Cancer Vaccines Sales Price Trend (2011-2021)
Table Russia Lung Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Russia Lung Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Russia Lung Cancer Vaccines Sales by Type (2015 and 2016)
Table Russia Lung Cancer Vaccines Market Share by Type (2015 and 2016)
Table Russia Lung Cancer Vaccines Sales by Applications (2015 and 2016)
Table Russia Lung Cancer Vaccines Market Share by Applications (2015 and 2016)
Figure Spain Lung Cancer Vaccines Sales and Growth Rate (2011-2021)
Figure Spain Lung Cancer Vaccines Revenue and Growth Rate (2011-2021)
Figure Spain Lung Cancer Vaccines Sales Price Trend (2011-2021)
Table Spain Lung Cancer Vaccines Sales by Manufacturers (2015 and 2016)
Table Spain Lung Cancer Vaccines Market Share by Manufacturers (2015 and 2016)
Table Spain Lung Cancer Vaccines Sales by Type (2015 and 2016)
Table Spain Lung Cancer Vaccines Market Share by Type (2015 and 2016)
Table Spain Lung Cancer Vaccines Sales by Applications (2015 and 2016)
Table Spain Lung Cancer Vaccines Market Share by Applications (2015 and 2016)
Table Boehringer Ingelheim Basic Information List
Table Lung Cancer Vaccines Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)
Table CureVac Basic Information List
Table Lung Cancer Vaccines Sales, Revenue, Price of CureVac (2015 and 2016)
Table Eli Lily Basic Information List
Table Lung Cancer Vaccines Sales, Revenue, Price of Eli Lily (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Lung Cancer Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table ImClone Systems Basic Information List
Table Lung Cancer Vaccines Sales, Revenue, Price of ImClone Systems (2015 and 2016)
Table Merck Basic Information List
Table Lung Cancer Vaccines Sales, Revenue, Price of Merck (2015 and 2016)
Table Ono Pharmaceutical Basic Information List
Table Lung Cancer Vaccines Sales, Revenue, Price of Ono Pharmaceutical (2015 and 2016)
Table Oncothyreon Incorporation Basic Information List
Table Lung Cancer Vaccines Sales, Revenue, Price of Oncothyreon Incorporation (2015 and 2016)
Table Basic Information List
Table Lung Cancer Vaccines Sales, Revenue, Price of (2015 and 2016)
Table Basic Information List
Table Lung Cancer Vaccines Sales, Revenue, Price of (2015 and 2016)
Table Merck Basic Information List